A randomised controlled trial of an online aftercare proram in pain rehabilitatio
Not yet recruiting
- Conditions
- chronic pain
- Registration Number
- NL-OMON27656
- Lead Sponsor
- Roessingh Research & Developmnt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 142
Inclusion Criteria
•Patients aged between 18 and 65 years old
•Primary complaint is chronic musculoskeletal pain
Exclusion Criteria
Dropped out of rehabilitation program
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main study outcome is pain interference measured by the Multidimensional Pain Inventory – subscale pain interference (MPI – interference) (Kerns et al., 1985; Lousberg et al., 1999).
- Secondary Outcome Measures
Name Time Method Pain Intensity measured by the Multidimensional Pain Inventory – subscale pain intensity (MPI – intensity) (Kerns et al., 1985; Lousberg et al., 1999). <br /><br>Psychological distress meadured by Hospital Anxiety Depression Scale (HADS) (Zigmond & Snaith, 1983). <br /><br>Psychological flexibility measured by <br>Psychological inflexibility in Pain Scale (PIPS) (Wicksell et al, 2010; Trompetter et al., 2014). <br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie digital health interventions in chronic pain rehabilitation, such as neuroplasticity or central sensitization modulation?
How does the NL-OMON27656 online aftercare program compare to standard-of-care in-person physiotherapy for chronic pain recurrence prevention?
Which biomarkers, like inflammatory cytokines or neuroimaging patterns, predict response to eHealth-based pain rehabilitation in NL-OMON27656?
What adverse events are associated with telemedicine-based chronic pain aftercare, and how are they managed in the Roessingh Research & Development trial?
How does the NL-OMON27656 program integrate with pharmacological treatments like SNRIs or NSAIDs for chronic pain maintenance therapy?